Latest Articles

Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia.

The Gut-Endometriosis Axis: Genetic Mechanisms and Public Health Implications.

Background/Objectives: Endometriosis is a chronic, estrogen-driven gynecological disorder affecting approximately 10% of reproductive-aged women worldwide, with significant physical, psychosocial, and socioeconomic impacts. Recent research suggests a possible involvement of the …

Relugolix in Monotherapy and Combined Therapy for the Treatment of Uterine Diseases and Its Effects on Bones: A Systematic Review.

Background: Uterine fibroids (UFs) and endometriosis are gynecological conditions that significantly increase morbidity among women of reproductive age. Relugolix, a novel gonadotropin-releasing hormone receptor antagonist, is approved in combined therapy …

National endometriosis plan sees no real increase in take-up of treatments - The University of Queensland

National endometriosis plan sees no real increase in take-up of treatments The University of Queensland

Isolated Adenomyosis Linked to Fewer Systemic Comorbidities Compared to Coexisting Endometriosis: Study... - Medical Dialogues

Isolated Adenomyosis Linked to Fewer Systemic Comorbidities Compared to Coexisting Endometriosis: Study... Medical Dialogues

A new generation test can find traces of endometriosis in menstrual blood - evidencenetwork.ca

A new generation test can find traces of endometriosis in menstrual blood evidencenetwork.ca

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology - Pharmafile

Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology Pharmafile

MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass - Inquirer.net

MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass Inquirer.net

Endometriosis Rates Increasing Across All Ages, Most Common in Women 35–49 - Epic Research

Endometriosis Rates Increasing Across All Ages, Most Common in Women 35–49 Epic Research

UHNM awarded £250,000 in government funding to launch pioneering endometriosis trial - University Hospitals of North Midlands

UHNM awarded £250,000 in government funding to launch pioneering endometriosis trial University Hospitals of North Midlands